Hyperion Defi, Inc.
HYPD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001682639
No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Hyperion Defi, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 26 | 26 | 0 |
| Shares | 1.87M | 1.92M | +53.6K (+2.9%) |
| Value | $9.28M | $9.44M | +$161.0K (+1.7%) |
New holders (5)
Institutions that held Hyperion Defi, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HN Saltoro Capital, LP | 173,779 | $852.0K | 0.68% |
| Oak Family Advisors, LLC | 53,706 | $263.0K | 0.14% |
| Susquehanna International Group, LLP | 22,327 | $109.0K | 0.00% |
| State Street Corp | 18,700 | $92.0K | 0.00% |
| Deutsche Bank AG | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Hyperion Defi, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 20,658 | $102.0K |
| Jane Street Group, LLC | 12,955 | $64.0K |
| Dimensional Fund Advisors LP | 12,546 | $62.0K |
| Citigroup Inc | 6,007 | $30.0K |
| Tower Research Capital LLC (TRC) | 1,931 | $9.00K |